Document Detail


Effects of lifestyle interventions on inflammatory markers in the metabolic syndrome.
MedLine Citation:
PMID:  21196367     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Metabolic syndrome (MetS) is a clustering of cardiovascular risk factors which places individuals at increased risk for cardiovascular morbidity and mortality. In addition to obesity and insulin resistance, inflammation is emerging as a potential etiologic factor of the syndrome. One hypothesis suggests that obesity contributes to insulin resistance through increased production of adipose-derived inflammatory cytokines. Currently, lifestyle change is the first line of treatment for MetS. Only recently, however, have studies begun exploring the effect of lifestyle interventions on the mediation of inflammation in individuals with MetS. This review summarizes the strongest evidence (i.e. randomized controlled trial data) for a role of lifestyle interventions (diet and/or exercise) on the improvement of inflammatory biomarkers in people with MetS. Of six studies assessed, lifestyle interventions were consistently successful at improving the inflammatory and metabolic profiles. Interestingly, improvements in the inflammatory profile were found to be largely independent of obesity. Data currently suggest that alterations in dietary composition may be the most effective lifestyle change, although there is a need for more research in this area.
Authors:
Kristen M Beavers; Barbara J Nicklas
Related Documents :
12064787 - Articulation in prader-willi syndrome.
17761457 - Hormonal management of premenstrual syndrome.
15470827 - Pharmacologic treatment of cognitive deficits and hypersexuality due to "shaken-baby sy...
3674117 - Clinical heterogeneity associated with deletions in the long arm of chromosome 15: repo...
21915637 - Acute motor-sensory axonal guillain-barré syndrome with unilateral facial nerve paraly...
2370887 - An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryp...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review     Date:  2011-01-01
Journal Detail:
Title:  Frontiers in bioscience (Scholar edition)     Volume:  3     ISSN:  1945-0524     ISO Abbreviation:  Front Biosci (Schol Ed)     Publication Date:  2011  
Date Detail:
Created Date:  2011-01-03     Completed Date:  2011-05-17     Revised Date:  2012-05-04    
Medline Journal Info:
Nlm Unique ID:  101485241     Medline TA:  Front Biosci (Schol Ed)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  168-77     Citation Subset:  IM    
Affiliation:
J. Paul Sticht Center on Aging, Department of Internal Medicine, Section on Gerontology and Geriatric Medicine, Wake Forest, University School of Medicine, Winston-Salem, North Carolina 27157, USA. kbeavers@wfubmc.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Markers / metabolism
C-Reactive Protein / metabolism
Cytokines / metabolism
Fibrinogen / metabolism
Humans
Inflammation / diet therapy,  epidemiology,  therapy*
Leukocyte Count
Metabolic Syndrome X / diet therapy,  epidemiology,  therapy*
Prevalence
Risk Reduction Behavior*
Grant Support
ID/Acronym/Agency:
AG027529/AG/NIA NIH HHS; HL093713/HL/NHLBI NIH HHS; R01 AG027529-01A1/AG/NIA NIH HHS; R01 AG027529-02/AG/NIA NIH HHS; R01 AG027529-03/AG/NIA NIH HHS; R01 AG027529-04/AG/NIA NIH HHS; R01 HL093713/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Cytokines; 9001-32-5/Fibrinogen; 9007-41-4/C-Reactive Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Diagnosis and monitoring of chronic viral hepatitis: serologic and molecular markers.
Next Document:  Neurogenesis, NSCs, pathogenesis and therapies for Alzheimer's disease.